None listed
Conditions
Brief summary
The Paediatric Research in Emergency Departments International Collaborative (PREDICT) network developed an Australasian Bronchiolitis Guideline in 2016 that provided high quality evidence that widely used interventions were ineffective. The PREDICT ‘Knowledge Translation in Australasian Paediatric Acute Care Settings: a multi-centred, cluster-randomised controlled trial comparing a tailored, theory informed Knowledge Translation intervention versus passive dissemination of a bronchiolitis guideline’ (PREDICT Bronchiolitis KT study) (ACTRN12616001567415), multicentred, cluster, randomised controlled trial found that targeted, theory-informed bronchiolitis interventions were effective in reducing the use of five inappropriate therapies (chest X-ray, salbutamol, glucocorticoids, antibiotics, and adrenaline) compared to passive dissemination of a guideline. The aim of this study is to assess sustainability of these improvements at the 26 sites which participated in the PREDICT Bronchiolitis KT study, one (2018) and two years (2019) post implementation of intervention. A retrospective medical audit will be conducted at the 26 Australian and New Zealand hospitals which participated in the PREDICT Bronchiolitis KT study. Our results will help determine the sustainability of this intervention over time, determine any improvements in control group hospitals, examine the learning and decay effects of the intervention, determine fidelity and adaptation of the intervention and explore factors which may have contributed to sustained improvements in either intervention or control group sites.
Interventions
The 2017 PREDICT ‘Knowledge Translation in Australasian Paediatric Acute Care Settings: a multi-centred, cluster-randomised controlled trial comparing a tailored, theory informed Knowledge Translation intervention versus passive dissemination of a bronchiolitis guideline’ study (PREDICT Bronchiolitis Knowledge Translation (KT) Study) (ACTRN12616001567415), successfully implemented a targeted, theory-informed bronchiolitis intervention which reduced the use of five inappropriate therapies (chest X-ray, salbutamol, glucocorticoids, antibiotics, and adrenaline). The intervention included the following components: engagement of local nursing and medical clinical opinion leaders; a one-day train the trainer workshop; educational materials; and audit and feedback. Our study will undertake medical record audits at the 13 intervention trial hospitals to determine the sustainability of this intervention over time including any improvements. Medical record audits will be conducted on infants who presented to hospital between 1 January 2018 to 31 December 2019, with a diagnosis of bronchiolitis. Data will be extracted on patient demographics; chest x-ray; medication administration (salbutamol, antibiotic, glucocorticoid, adrenaline); respiratory support (non-invasive or invasive ventilation) and disposition from emergency department or inpatient paediatric area (i.e., discharged home or admitted to Intensive Care Unit). Semi-structured interviews (individual or group - depending on clinician availability, via teleconference or face-to-face) will be conducted at 13 intervention trial hospital sites to determine fidelity and adaptation of the intervention and explore factors which may have contributed to improvements in intervention group hospitals. The semi-structured interviews will be approximately 30-45 minutes in duration and will be conducted by two study researchers with a convenience sample of doctors and nurses who treat infants in the participating EDs and inpatient paediatric areas. There will be a maximum of three to five individuals per site (n=78-130).
Sponsors
Eligibility
Inclusion criteria
Medical Record Audit Inclusion Criteria Hospital Inclusion Criteria: Twenty-six hospitals (Australia= 20 and New Zealand = 6) which participated in the PREDICT Bronchiolitis KT study (ACTRN12616001567415) conducted in 2017 will be invited to participate. In addition, to be eligible for this study, hospitals must have the ability to collect the required retrospective patient data from the medical records within a timely fashion and meet local governance requirements. Patient Inclusion Criteria: • Infants aged less than 12 months (at time of presentation), AND • A recorded diagnosis of bronchiolitis on discharge from ED to home, OR • A diagnosis of bronchiolitis on discharge from inpatient area AND a recorded diagnosis of bronchiolitis in ED. Qualitative Group Interview Inclusion Criteria Hospital Inclusion Criteria: Twenty-six hospitals which participated in the PREDICT Bronchiolitis KT study conducted in 2017 will be invited to participate. In addition, to be eligible for this section of the study, hospitals must have agreed to participate in the retrospective medical records audit. Clinician Inclusion Criteria: Participants must be: • on an active practice roster • working part-time or full-time • in a clinical role as either doctors (including trainees) and registered nurses who are responsible for caring for children with bronchiolitis in an Australian or New Zealand EDs or paediatric inpatient areas. Where possible Clinical Leads from the PREDICT Bronchiolitis KT study will be included in the sample as will clinicians of varying seniority (years since completing training).
Exclusion criteria
Medical Record Audit Exclusion Criteria: Hospital Exclusion Criteria: There are no hospital level exclusion criteria. Patient Exclusion Criteria: There are no patient level exclusion criteria. Clinician Exclusion Criteria: Hospital Exclusion Criteria: There are no hospital level exclusion criteria. Clinician Exclusion Criteria: Students/interns, locums (medical); agency or bank staff (nurses) and clinicians not currently engaged in clinical practice will be excluded.